Medications to reduce blood loss during C-section hysterectomy for PAS
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests if giving a special medication during surgery can help reduce blood loss in women with a condition called PAS (where the placenta grows too deeply into the uterus) who are having a C-section and their uterus removed. It may make the surgery safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with a single baby.
- You have had one or more previous C-sections.
- Your pregnancy is more than 32 weeks along.
- Ultrasound has shown signs that the placenta is attached abnormally (PAS).
- Your hemoglobin level before surgery is above 10 g/dL.
- You are scheduled for a C-section and removal of the uterus (hysterectomy) due to PAS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods (a cervical tourniquet and tying off the uterine artery) to control bleeding during a c-section for women with placenta accreta. If you are having an elective c-section at 36 weeks or later for this condition, this trial may help reduce blood loss.
This trial is studying a new approach to prevent and treat a pregnancy complication called placenta accreta spectrum (where the placenta grows too deeply into the uterus). It aims to help pregnant women diagnosed with this condition improve their outcomes.
This trial tests a different way to manage placenta accreta that avoids removing the uterus (hysterectomy). It is for pregnant people who want to keep their uterus and would otherwise need a hysterectomy during childbirth.
This trial tests a specialized surgical technique to treat placenta accreta spectrum (a serious condition where the placenta grows too deeply into the uterus) while preserving your uterus instead of removing it. The goal is to help you keep your ability to have future pregnancies.
This trial tests whether a balloon placed in a major artery (REBOA) can help reduce dangerous blood loss during cesarean delivery for women with placenta accreta. If you have this condition and are planning a c-section at 34 weeks or more, this study may offer an extra safety measure.
This study looks at how type of anesthesia (spinal vs. general) affects mothers and babies during planned cesarean deliveries in pregnancies with placenta accreta spectrum, a condition where the placenta grows too deeply into the uterus.
Hear when a new Placenta Accreta Spectrum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.